Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API

Irina Liverko

35 та иш

1Republican Specialized Scientific and Practical Medical Center of Phthisiology and Pulmonology, Tashkent, Uzbekistan

  1. The effectiveness of pulmonary tuberculosis treatment during the COVID-19 pandemic

    Ruzilya Usmanova, Nargiza Parpieva, Irina Liverko +6

    МақолаCOVID-19 Prevention and Impact20240 иқтибос
    ABI

  2. The Effectiveness and Safety of Bedaquiline, Pretomanid, and Linezolid (BPaL)–Based Regimens for Rifampicin-Resistant Tuberculosis in Non-Trial Settings—A Prospective Cohort Study in Belarus and Uzbekistan

    Animesh A. Sinha, Robert J. Klebe, Michael L. Rekart +22

    МақолаTuberculosis Research and EpidemiologyClinical Infectious Diseases20250 иқтибос
    ABI

  3. Cardiac markers in COPD comorbidity with sleep apnea hypopnea syndrome

    Irina Liverko, Elnorahon Abduganieva, Xayrullo Rajabov

    МақолаObstructive Sleep Apnea Research20250 иқтибос
    ABI

  4. The association between obstructive sleep apnea and vitamin d deficiency in patients with chronic obstructive pulmonary disease

    Khayrillo Rajabov, Irina Liverko

    МақолаChronic Obstructive Pulmonary Disease (COPD) Research20250 иқтибос
    ABI

  5. Evaluation of TB treatment outcomes in outpatient settings during the COVID-19 pandemic

    Ruzilya Usmanova, Nargiza Parpieva, Irina Liverko

    МақолаTuberculosis Research and Epidemiology20250 иқтибос
    ABI

  6. Streptococcal bacteriophage and Prevenar-13 vaccine are comparably effective in Pneumococcal pneumonia in patients with COPD

    Rano Nalibaeva, Irina Liverko

    МақолаPneumonia and Respiratory Infections20250 иқтибос
    ABI

  7. Characterization of Diagnosed Streptococcus pneumoniae Serotypes in COPD Patients

    Rano Nalibaeva, Irina Liverko

    МақолаPneumonia and Respiratory Infections20250 иқтибос
    ABI

  8. Homocysteine as prognostic biomarker for increased inflammatory responses in chronic obstructive pulmonary disease

    Elnorahon Abduganieva, Irina Liverko, Shaxnoza Kuchkarova

    МақолаFolate and B Vitamins Research20250 иқтибос
    ABI

  9. Frequency and risk assessment of obstructive sleep apnea in patients with chronic obstructive pulmonary disease

    Khayrillo Rajabov, Irina Liverko

    МақолаObstructive Sleep Apnea Research20250 иқтибос
    ABI

  10. Quality of life outcomes and patient-reported experiences in a randomised controlled trial for rifampicin-resistant TB (PRACTECAL-PRO): a mixed-methods study

    Karen Lowton, Beverley Stringer, M. Cusinato +7

    МақолаTuberculosis Research and EpidemiologyIJTLD OPEN20260 иқтибос
    ABI